Table of Contents
Advances in Regenerative Medicine
Volume 2014 (2014), Article ID 426520, 8 pages
http://dx.doi.org/10.1155/2014/426520
Review Article

Role of Erythropoietin and Other Growth Factors in Ex Vivo Erythropoiesis

1Stem Cell Research Laboratory, Department of Biotechnology, Delhi Technological University, Shahbad Daulatpur, Bawana Road, Delhi 110042, India
2Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India

Received 28 April 2014; Accepted 9 September 2014; Published 2 October 2014

Academic Editor: Thomas Ichim

Copyright © 2014 Vimal Kishor Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Global Database on Blood Safety: Summary Report [Internet], World Health Organization, 2012, http://www.who.int/bloodsafety/global_database/GDBS_Summary_Report_2011.pdf.
  2. L. Douay, H. Lapillonne, and A. G. Turhan, “Stem cells-A source of adult red blood cells for transfusion purposes: present and future,” Critical Care Clinics, vol. 25, no. 2, pp. 383–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. A. Neildez-Nguyen, H. Wajcman, M. C. Marden et al., “Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo,” Nature Biotechnology, vol. 20, no. 5, pp. 467–472, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-C. Giarratana, L. Kobari, H. Lapillonne et al., “Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells,” Nature Biotechnology, vol. 23, no. 1, pp. 69–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. E. J. Baek, H.-S. Kim, S. Kim, H. Jin, T.-Y. Choi, and H. O. Kim, “In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells,” Transfusion, vol. 48, no. 10, pp. 2235–2245, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. J. Baek, H.-S. Kim, J.-H. Kim, N. J. Kim, and H. O. Kim, “Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer,” Transfusion, vol. 49, no. 11, pp. 2285–2295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Fujimi, T. Matsunaga, M. Kobune et al., “Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages,” International Journal of Hematology, vol. 87, no. 4, pp. 339–350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. N. E. Timmins, S. Athanasas, M. Günther, P. Buntine, and L. K. Nielsen, “Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells,” Tissue Engineering C: Methods, vol. 17, no. 11, pp. 1131–1137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Adamson, The Story of Erythropoietin: ASH Anniversary Brochure, 50 Years in Hematology: Research That Revolutionized Patient Care, 2009.
  10. C. J. Gregory and A. C. Eaves, “Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties,” Blood, vol. 51, no. 3, pp. 527–537, 1978. View at Google Scholar · View at Scopus
  11. R. S. Hillman and P. A. Henderson, “Control of marrow production by the level of iron supply,” The Journal of Clinical Investigation, vol. 48, no. 3, pp. 454–460, 1969. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Yu, J. J. Shacka, J. B. Eells et al., “Erythropoietin receptor signalling is required for normal brain development,” Development, vol. 129, no. 2, pp. 505–516, 2002. View at Google Scholar · View at Scopus
  13. B. R. Smith, “Regulation of hematopoiesis,” Yale Journal of Biology and Medicine, vol. 63, no. 5, pp. 371–380, 1990. View at Google Scholar · View at Scopus
  14. V. Munugalavadla and R. Kapur, “Role of c-Kit and erythropoietin receptor in erythropoiesis,” Critical Reviews in Oncology/Hematology, vol. 54, no. 1, pp. 63–75, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. O. Arcasoy, K. Amin, S.-C. Chou, Z. A. Haroon, M. Varia, and J. A. Raleigh, “Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia,” Clinical Cancer Research, vol. 11, no. 1, pp. 20–27, 2005. View at Google Scholar · View at Scopus
  16. H. Kawada, K. Ando, T. Tsuji et al., “Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system,” Experimental Hematology, vol. 27, no. 5, pp. 904–915, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-S. Jiang, C. Chai, Y. Zhang, R.-X. Zhuo, H.-Q. Mao, and K. W. Leong, “Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells,” Biomaterials, vol. 27, no. 13, pp. 2723–2732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Drouet, J. Mathieu, N. Grenier, E. Multon, J.-J. Sotto, and F. Herodin, “The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation,” Stem Cells, vol. 17, no. 5, pp. 273–285, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. P. H. Lai, R. Everett, F. F. Wang, T. Arakawa, and E. Goldwasser, “Structural characterization of human erythropoietin,” The Journal of Biological Chemistry, vol. 261, no. 7, pp. 3116–3121, 1986. View at Google Scholar · View at Scopus
  20. M. L. Law, G. Y. Cai, F. K. Lin et al., “Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 18, pp. 6920–6924, 1986. View at Publisher · View at Google Scholar · View at Scopus
  21. A.-L. Sirén, M. Fratelli, M. Brines et al., “Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4044–4049, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Motoyoshi, “Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO),” Nippon Rinsho, vol. 50, no. 8, pp. 1967–1972, 1992. View at Google Scholar · View at Scopus
  23. C. A. Sieff, C. M. Niemeyer, D. G. Nathan et al., “Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3,” Journal of Clinical Investigation, vol. 80, no. 3, pp. 818–823, 1987. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Carnot and C. DeFlandre, “Surlactivite hemopoietique de serum au cours de la regeneration du sang,” Comptes Rendus de l'Académie des Sciences, vol. 143, pp. 384–386, 1906. View at Google Scholar
  25. E. Hjort, “Reticulocyte increase after injection of anemic serum,” Mag F Laegividensk, vol. 97, pp. 270–277, 1936. View at Google Scholar
  26. J. W. Fisher, “Erythropoietin: physiology and pharmacology update,” Experimental Biology and Medicine, vol. 228, no. 1, pp. 1–14, 2003. View at Google Scholar
  27. H. Wu, X. Liu, R. Jaenisch, and H. F. Lodish, “Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor,” Cell, vol. 83, no. 1, pp. 59–67, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-S. Lin, S.-K. Lim, V. D'Agati, and F. Costantini, “Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erytnropoiesis,” Genes and Development, vol. 10, no. 2, pp. 154–164, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Chiba, Y. Ikawa, and K. Todokoro, “GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression,” Nucleic Acids Research, vol. 19, no. 14, pp. 3843–3848, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. H. M. Rogers, X. Yu, J. Wen, R. Smith, E. Fibach, and C. T. Noguchi, “Hypoxia alters progression of the erythroid program,” Experimental Hematology, vol. 36, no. 1, pp. 17–27, 2008. View at Google Scholar
  31. M. Ogilvie, X. Yu, V. Nicolas-Metral et al., “Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts,” Journal of Biological Chemistry, vol. 275, no. 50, pp. 39754–39761, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. S. N. Constantinescu, T. Keren, M. Socolovsky, H.-S. Nam, Y. I. Henis, and H. F. Lodish, “Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4379–4384, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Raddino, D. Robba, G. Caretta et al., “Erythropoietin: a new perspective in cardiovascular therapy,” Monaldi Archives for Chest Disease—Cardiac Series, vol. 70, no. 4, pp. 206–213, 2008. View at Google Scholar · View at Scopus
  34. B. Wognum, “Erythropoietin mini review”.
  35. M. O. Arcasoy, “The non-haematopoietic biological effects of erythropoietin,” British Journal of Haematology, vol. 141, no. 1, pp. 14–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Chen and A. J. Sytkowski, “Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 38518–38526, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. S. B. Krantz, “Erythropoietin,” Blood, vol. 77, no. 3, pp. 419–434, 1991. View at Google Scholar · View at Scopus
  38. P. N. Pharr, A. Hofbauer, R. E. Worthington, and G. D. Longmore, “Residual erythroid progenitors in w/w mice respond to erythropoietin in the absence of steel factor signals,” International Journal of Hematology, vol. 72, no. 2, pp. 178–185, 2000. View at Google Scholar · View at Scopus
  39. R. Kapur and L. Zhang, “A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin,” The Journal of Biological Chemistry, vol. 276, no. 2, pp. 1099–1106, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. J. R. Stubbs, “Alternatives to blood product transfusion in the critically ill: erythropoietin,” Critical Care Medicine, vol. 34, no. 5, pp. S160–S169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Okazaki, S. Ebihara, H. Takahashi, M. Asada, A. Kanda, and H. Sasaki, “Macrophage colony-stimulating factor induces vascular endothelial growth factor production in skeletal muscle and promotes tumor angiogenesis,” The Journal of Immunology, vol. 174, no. 12, pp. 7531–7538, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Okazaki, S. Ebihara, M. Asada, A. Kanda, H. Sasaki, and M. Yamaya, “Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models,” International Immunology, vol. 18, no. 1, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Folkman, “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nature Medicine, vol. 1, no. 1, pp. 27–31, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Ferrara and R. S. Kerbel, “Angiogenesis as a therapeutic target,” Nature, vol. 438, no. 7070, pp. 967–974, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Okazaki, S. Ebihara, M. Asada, S. Yamanda, K. Niu, and H. Arai, “Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis,” Neoplasia, vol. 10, no. 9, pp. 932–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Inaba, M. Inaba, N. Romani et al., “Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor,” Journal of Experimental Medicine, vol. 176, no. 6, pp. 1693–1702, 1992. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Metcalf and N. A. Nicola, The Hematopoietic Colony Stimulating Factors, Cambridge University Press, New York, NY, USA, 1995.
  48. N. A. Nicola and D. Metcalf, “Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells,” Journal of Cellular Physiology, vol. 124, no. 2, pp. 313–321, 1985. View at Publisher · View at Google Scholar · View at Scopus
  49. B. J. McClure, T. R. Hercus, B. A. Cambareri et al., “Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex,” Blood, vol. 101, no. 4, pp. 1308–1315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Geijsen, L. Koenderman, and P. J. Coffer, “Specificity in cytokine signal transduction: Lessons learned from the IL-3/IL-5/GM-CSF receptor family,” Cytokine & Growth Factor Reviews, vol. 12, no. 1, pp. 19–25, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. J. N. Ihle, L. Pepersack, and L. Rebar, “Regulation of T cell differentiation: in vitro induction of 20α-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine,” Journal of Immunology, vol. 126, no. 6, pp. 2184–2189, 1981. View at Google Scholar · View at Scopus
  52. J. N. Ihle, Y. Weinstein, J. Keller, L. Henderson, and E. Palaszynski, “Interleukin 3,” Methods in Enzymology, vol. 116, pp. 540–552, 1985. View at Publisher · View at Google Scholar · View at Scopus
  53. Entrez Gene: CSF1 colony stimulating factor 1 (macrophage).
  54. E. R. Stanley, K. L. Berg, D. B. Einstein et al., “Biology and action of colony—stimulating factor-1,” Molecular Reproduction and Development, vol. 46, no. 1, pp. 4–10, 1997. View at Google Scholar
  55. J. Nemunaitis, “Macrophage function activating cytokines: potential clinical application,” Critical Reviews in Oncology/Hematology, vol. 14, no. 2, pp. 153–171, 1993. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Metcalf, “The granulocyte-macrophage colony-stimulating factors,” Science, vol. 229, no. 4708, pp. 16–22, 1985. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Nagata, M. Tsuchiya, S. Asano et al., “Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor,” Nature, vol. 319, no. 6052, pp. 415–418, 1986. View at Publisher · View at Google Scholar · View at Scopus
  58. L. M. Souza, T. C. Boone, J. Gabrilove et al., “Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells,” Science, vol. 232, no. 4746, pp. 61–65, 1986. View at Publisher · View at Google Scholar · View at Scopus
  59. J. W. Adamson, “Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans,” Biotechnology, vol. 19, pp. 351–363, 1991. View at Google Scholar · View at Scopus
  60. J. W. Adamson, “The relationship of erythropoietin and iron metabolism to red blood cell production in humans,” Seminars in Oncology, vol. 21, no. 2, supplement 3, pp. 9–15, 1994. View at Google Scholar · View at Scopus
  61. J. W. Adamson, “The erythropoietin-hematocrit relationship in normal and polycythemic man: implications of marrow regulation.,” Blood, vol. 32, no. 4, pp. 597–609, 1968. View at Google Scholar · View at Scopus
  62. A. P. Walden, J. D. Young, and E. Sharples, “Bench to bedside: a role for erythropoietin in sepsis,” Critical Care, vol. 14, no. 4, article 227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Bieber, “Erythropoietin, the biology of erythropoiesis and epoetin alfa: an overview,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 46, no. 5, pp. 521–530, 2001. View at Google Scholar · View at Scopus
  64. G. Dranoff, E. Jaffee, A. Lazenby et al., “Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 8, pp. 3539–3543, 1993. View at Publisher · View at Google Scholar · View at Scopus
  65. W. Schmidt, M. Buschle, W. Zauner et al., “Cell-free tumor antigen peptide-based cancer vaccines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3262–3267, 1997. View at Publisher · View at Google Scholar · View at Scopus